207 related articles for article (PubMed ID: 36238306)
1. N-3 polyunsaturated fatty acids may affect the course of COVID-19.
Lampova B; Doskocil I; Kourimska L; Kopec A
Front Immunol; 2022; 13():957518. PubMed ID: 36238306
[TBL] [Abstract][Full Text] [Related]
2. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.
Mazidimoradi A; Alemzadeh E; Alemzadeh E; Salehiniya H
Life Sci; 2022 Jun; 299():120489. PubMed ID: 35358595
[TBL] [Abstract][Full Text] [Related]
3. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?
Weill P; Plissonneau C; Legrand P; Rioux V; Thibault R
Biochimie; 2020 Dec; 179():275-280. PubMed ID: 32920170
[TBL] [Abstract][Full Text] [Related]
4. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
Darwesh AM; Bassiouni W; Sosnowski DK; Seubert JM
Pharmacol Ther; 2021 Mar; 219():107703. PubMed ID: 33031856
[TBL] [Abstract][Full Text] [Related]
5. Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer.
Story MJ
Biochimie; 2021 Aug; 187():94-109. PubMed ID: 34082041
[TBL] [Abstract][Full Text] [Related]
6. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the
Arnardottir H; Pawelzik SC; Öhlund Wistbacka U; Artiach G; Hofmann R; Reinholdsson I; Braunschweig F; Tornvall P; Religa D; Bäck M
Front Physiol; 2020; 11():624657. PubMed ID: 33505321
[TBL] [Abstract][Full Text] [Related]
7. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19.
Yang CP; Chang CM; Yang CC; Pariante CM; Su KP
Brain Behav Immun; 2022 Jul; 103():19-27. PubMed ID: 35390469
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
9. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
Torrinhas RS; Calder PC; Lemos GO; Waitzberg DL
Nutrition; 2021 Jan; 81():110900. PubMed ID: 32738510
[TBL] [Abstract][Full Text] [Related]
10. Current evidence on ω-3 fatty acids in enteral nutrition in the critically ill: A systematic review and meta-analysis.
Kristine Koekkoek W; Panteleon V; van Zanten AR
Nutrition; 2019 Mar; 59():56-68. PubMed ID: 30419501
[TBL] [Abstract][Full Text] [Related]
11. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial.
Doaei S; Gholami S; Rastgoo S; Gholamalizadeh M; Bourbour F; Bagheri SE; Samipoor F; Akbari ME; Shadnoush M; Ghorat F; Mosavi Jarrahi SA; Ashouri Mirsadeghi N; Hajipour A; Joola P; Moslem A; Goodarzi MO
J Transl Med; 2021 Mar; 19(1):128. PubMed ID: 33781275
[TBL] [Abstract][Full Text] [Related]
12. Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids.
Jeyakumar SM; Vajreswari A
World J Clin Cases; 2021 Nov; 9(31):9333-9349. PubMed ID: 34877270
[TBL] [Abstract][Full Text] [Related]
13. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
14. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU lipids study.
Grau-Carmona T; Bonet-Saris A; García-de-Lorenzo A; Sánchez-Alvarez C; Rodríguez-Pozo A; Acosta-Escribano J; Miñambres E; Herrero-Meseguer JI; Mesejo A
Crit Care Med; 2015 Jan; 43(1):31-9. PubMed ID: 25226273
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
Zhang Y; Chen Y; Meng Z
Front Immunol; 2020; 11():577442. PubMed ID: 33240265
[TBL] [Abstract][Full Text] [Related]
16. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
[TBL] [Abstract][Full Text] [Related]
17. Regarding: "The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial".
Nakata T; Ariie T; Taito S
J Transl Med; 2021 Jun; 19(1):282. PubMed ID: 34193209
[No Abstract] [Full Text] [Related]
18. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
19. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
20. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
